HMGCR and central nervous system cancer: We next evaluated the roles of HMGCR in the progression of glioma and found that HMGCR knockdown could inhibit the anchorage‐independent growth of U87 and U251 cells (Figure 2B), which actually mimicked the phenotype induced by ART treatment (Figure 1D).